{"id":"W2624955713","doi":"10.1007/s00192-017-3377-5","title":"A prospective, double-blind, randomized, two-period crossover, multicenter study to evaluate tolerability and patient preference between mirabegron and tolterodine in patients with overactive bladder (PREFER study)","year":2017,"lang":"en","type":"article","venue":"International Urogynecology Journal","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université de Sherbrooke; Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Astellas Foundation for Research on Metabolic Disorders; Astellas Pharma Global Development; Astellas Pharma","keywords":"Tolerability; Tolterodine; Mirabegron; Medicine; Overactive bladder; Crossover study; Adverse effect; Urology; Placebo; Clinical endpoint; Randomized controlled trial; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004304204,0.001227541,0.002887157,0.0003732926,0.000649584,0.0007731395,0.0007255718,0.001296309,0.005346009],"category_scores_gemma":[0.003653176,0.0009282552,0.001476623,0.0005610099,0.001146011,0.001024931,0.0004290964,0.001720726,0.0006723746],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005434544,"about_ca_system_score_gemma":0.001375253,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004241137,"about_ca_topic_score_gemma":0.0009924996,"domain_scores_codex":[0.9979194,0.001244802,0.0001835699,0.0003016995,0.0001971363,0.000153409],"domain_scores_gemma":[0.9967291,0.0009498082,0.001080059,0.0003191249,0.0001991825,0.0007227135],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9515799,0.02705356,0.004330198,0.0004535912,0.0007062937,0.00004072385,0.0001134242,0.0002092008,0.004620105,0.00005695662,0.0002850804,0.01055097],"study_design_scores_gemma":[0.6975308,0.2918374,0.009141453,0.00001689118,0.0002996314,0.00004695579,0.00002971448,0.0002382271,0.0003903136,0.00005135735,0.0003968706,0.00002037922],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9931574,0.0009435146,0.0006035221,0.0001326229,0.0001004767,0.00398763,0.0005525141,0.00003627101,0.0004860511],"genre_scores_gemma":[0.9849216,0.0007483318,0.003706008,0.0006746178,0.000389593,0.007853819,0.0006977072,0.00001545335,0.000992875],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005346009,"threshold_uncertainty_score":0.02276307,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04833139589838813,"score_gpt":0.3769485257264626,"score_spread":0.3286171298280745,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}